Ion channels as novel therapeutic targets in the treatment of pain.
about
TRPV1 Channel: A Potential Drug Target for Treating EpilepsyThe application of the Escherichia coli giant spheroplast for drug screening with automated planar patch clamp systemDual-pore glass chips for cell-attached single-channel recordings.TRESK background K(+) channel is inhibited by PAR-1/MARK microtubule affinity-regulating kinases in Xenopus oocytesThe LQLP calcineurin docking site is a major determinant of the calcium-dependent activation of human TRESK background K+ channel.Pharmacogenetics of new analgesics.High Proteolytic Resistance of Spider-Derived Inhibitor Cystine KnotsAristolochic acid, a plant extract used in the treatment of pain and linked to Balkan endemic nephropathy, is a regulator of K2P channels.Potassium channels in peripheral pain pathways: expression, function and therapeutic potential.Furanocoumarins are a novel class of modulators for the transient receptor potential vanilloid type 1 (TRPV1) channel.Two-pore domain potassium channels: potential therapeutic targets for the treatment of pain.Discovery of functional antibodies targeting ion channels.Membrane ion Channels and Receptors in Animal lifespan Modulation.Using automated patch clamp electrophysiology platforms in pain-related ion channel research: insights from industry and academia.Venom: the sharp end of pain therapeuticsReconstitution of Human Ion Channels into Solvent-free Lipid Bilayers Enhanced by Centrifugal Forces.Functional TRPV and TRPM channels in human preadipocytes.GI-530159, a novel, selective, mechanosensitive two-pore-domain potassium (K2P ) channel opener, reduces rat dorsal root ganglion neuron excitability.
P2860
Q26786478-CC019DF6-1657-49CF-9BEE-80B7C8614210Q33782923-CA4B802C-89C4-4A41-8AD2-50A5490C4CAEQ33999180-19A072EB-ABC1-4028-89FE-2983E7A03790Q34092421-D5677763-F928-4696-9226-B24CAC241DE5Q34396710-D67FA0F8-A68A-49E6-AB9F-CDE60BA2ACF0Q35005640-3FC1706A-41EF-47F6-A41D-B365F04C0214Q36457208-225FDE22-608E-49E1-822B-815457AAEFF4Q36830145-D8FAD36E-FB5E-4A50-A9C2-CABAA9F3440DQ37362041-DC29B961-7C75-4689-B39E-87049CE03C95Q37683369-BF6C0D2C-F60B-4E39-92C1-C27F78DD7FF5Q38270913-29EDF163-DCEC-4E41-B081-231FD25A8E5EQ38282832-77D7C6B3-13FB-4F3C-8444-7F1043586534Q39102539-7515BAC5-9E6D-407E-BCA4-102718645B79Q39378653-871A6FD3-CB9D-4570-8357-5E3832215428Q40376233-B5D9010F-75DF-432B-B80B-E710A9E62A1BQ42182972-B7B267B0-7264-482C-B720-21D7E8D5B341Q46174561-1D61C8BB-3755-4B51-8EA0-CCEAC53AC1ACQ48278693-D3FB29F0-FD39-4B25-BE60-AC47271F23EA
P2860
Ion channels as novel therapeutic targets in the treatment of pain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ion channels as novel therapeutic targets in the treatment of pain.
@en
Ion channels as novel therapeutic targets in the treatment of pain.
@nl
type
label
Ion channels as novel therapeutic targets in the treatment of pain.
@en
Ion channels as novel therapeutic targets in the treatment of pain.
@nl
prefLabel
Ion channels as novel therapeutic targets in the treatment of pain.
@en
Ion channels as novel therapeutic targets in the treatment of pain.
@nl
P2860
P1476
Ion channels as novel therapeutic targets in the treatment of pain.
@en
P2860
P304
P356
10.1111/J.2042-7158.2010.01131.X
P577
2010-09-01T00:00:00Z